Erika Yamamoto

TL;DR: For patients with acute coronary syndrome caused by plaque erosion, conservative treatment with anti-thrombotic therapy without stenting may be an option.

TL;DR: The presence of LRP in the nonculprit regions of the target vessel by OCT predicts increased risk for future NC-MACE, which is primarily driven by revascularization for recurrent ischemia.

TL;DR: The EROSION study as discussed by the authors showed that anti-thrombotic therapy without stenting is effective in reducing plaque erosion in patients with intravascular optical coherence tomography-based management in plaque erosion.

TL;DR: Healed plaques, a signature of prior plaque destabilization, were found at the culprit site in more than one-quarter of ACS patients, suggesting the combination of plaque vulnerability, local inflammation, and greater plaque burden in addition to systemic inflammation may outweigh the protective mechanism of plaque healing and predispose those plaques to develop occlusive thrombus.

TL;DR: This registry elucidated the clinical features and clinically relevant in-hospital outcomes in contemporary consecutive patients with acute decompensated heart failure in real-world clinical practice in Japan.